The Scientific Governance Framework refers to a structured approach designed to ensure that Real-World Evidence (RWE) analysis complies with applicable data use agreements, scientific review standards, and regulatory requirements while maintaining comprehensive accountability mechanisms. In the context of Medical Affairs operations, this framework establishes systematic protocols for managing access to sensitive healthcare data, documenting data utilization, and maintaining attribution records for audit and compliance purposes ¹⁾

A comprehensive Scientific Governance Framework typically comprises multiple integrated components that work in concert to protect data integrity and ensure regulatory compliance. The framework establishes request logging systems that create an immutable audit trail of all data access requests, including who requested the data, when the request was made, what specific data elements were accessed, and the stated purpose of the analysis. This documentation serves both as a compliance mechanism and as a mechanism for attribution, allowing organizations to track which analyses contributed to specific business decisions or regulatory submissions ²⁾

The framework incorporates data use agreements (DUAs) as binding contractual instruments that specify permissible uses of real-world evidence. These agreements define which organizational units or individuals may access specific datasets, what purposes are authorized, how long data may be retained, and what restrictions apply to secondary analysis or data sharing. The Scientific Governance Framework ensures that all proposed analyses are reviewed against DUA provisions before execution, preventing inadvertent violations and associated legal and regulatory consequences ³⁾

Scientific review represents a critical dimension of governance frameworks, ensuring that analyses meet established standards for methodological rigor, statistical validity, and scientific integrity. The framework typically establishes scientific review committees or designates qualified scientific advisors responsible for evaluating proposed analyses before data access is granted. These reviews assess whether study designs are appropriate for stated research questions, whether proposed statistical methods are sound, whether necessary confounding variables will be controlled, and whether conclusions are likely to be supported by the analytical approach.

This quality assurance function serves multiple purposes: it protects against publication of flawed analyses that could mislead healthcare providers or regulators, it ensures that scarce real-world evidence resources are allocated to scientifically valuable questions, and it reduces regulatory risk by ensuring transparency and methodological standards in analyses that may later be cited in regulatory submissions or promotional materials.

Central to Scientific Governance Frameworks is the establishment of clear accountability mechanisms that tie specific analyses to responsible individuals and organizational units. Comprehensive attribution systems document not only who conducted analysis, but also who approved the analysis plan, who reviewed the scientific methodology, and who authorized data access. This multi-layered accountability structure ensures that multiple quality checkpoints operate throughout the analytical process.

Request logging systems provide the technical foundation for accountability by creating searchable, tamper-resistant records of all data access activities. These logs typically capture metadata including access timestamps, user identifications, data elements accessed, analysis purposes, and associated approvals. Such systems enable organizations to respond rapidly to audit inquiries, investigate potential unauthorized access, and demonstrate compliance with data governance policies to regulators and data providers.

Medical Affairs departments utilize Scientific Governance Frameworks to manage analysis of real-world evidence while navigating complex regulatory environments and contractual obligations. Real-world evidence—data derived from healthcare claims databases, electronic health records, patient registries, and observational studies—provides valuable insights into how medical products perform in clinical practice. However, access to such data is typically restricted by contractual agreements, privacy regulations, and data provider policies.

The framework enables Medical Affairs teams to systematically evaluate requests for RWE analysis, ensure compliance with applicable restrictions, document scientific justification for analyses, and maintain accountability throughout the analytical lifecycle. This structured approach reduces regulatory risk while facilitating evidence generation that supports medical education, health economics research, comparative effectiveness studies, and regulatory submissions.

Implementing effective Scientific Governance Frameworks requires organizations to balance multiple competing objectives. Organizations must maintain sufficient rigor and documentation to ensure compliance and accountability, while avoiding bureaucratic processes so cumbersome that they delay time-sensitive analyses. Establishing appropriate scientific review thresholds—determining which analyses require formal review versus those that can proceed under streamlined processes—requires understanding of organizational risk tolerance and regulatory environment.

Integration of governance frameworks with modern data platforms presents technical challenges, as legacy systems may lack capabilities for fine-grained access controls, comprehensive audit logging, or automated enforcement of data use restrictions. Organizations increasingly implement these frameworks through combinations of technical controls (database-level access restrictions, automated logging), policy documents (data use agreements, analytical guidelines), and organizational processes (scientific review committees, approval workflows).

• FDA Real-World Evidence Framework
• Real-World Evidence (RWE)
• RWE Fluency Gap